Get started
Opening (IRA): PLTR May 16th 90 Covered Call... for a 76.56 debit. Comments: After taking off my iron condor for a loss, structuring a covered call such that the max profit potential is greater than the loss experienced by the nondirectional of 13.11. Metrics: Buying Power Effect/Break Even: 76.56 Max Profit: 13.44 ROC at Max: 17.55% Will generally look to roll out the short call out and/or down and out at intervals to increase profit potential and/or reduce downside break even ... .
NASDAQ:PLTRLong
by NaughtyPines
Angi | ANGI | Long at $20.05***New analysis / price targets given the recent 1/10 split:** The historical simple moving average (SMA) I've selected for Angi (formerly Angie's List Inc) NASDAQ:ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled in the future. 70M float, 20% short interest... Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency. Thus at $20.05, NASDAQ:ANGI is in a personal buy zone (this is the adjusted price from the original entry in December 2024 at $2.00, post 1/10 split). There absolutely could be more downside aside for this stock, but it is a personal buy and hold for the coming years (unless fundamentals drastically change). Targets: $22.50 $25.00 $30.00 $37.00
NASDAQ:ANGILong
by WorthlessViews
Angi's List | ANGI | Long at $2.00The historical simple moving average (SMA) I've selected for Angi Inc NASDAQ:ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled "soon". 70M float, 12% short interest... Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency. Thus at $2.00, NASDAQ:ANGI is in a personal buy zone. Target #1 = $2.25 Target #2 = $2.50 Target #3 = $3.00 Target #4 = $3.50 Target #5 = $3.70
NASDAQ:ANGILong
by WorthlessViews
Learn how to identify Fundamental levels with Technical AnalysisYes, you can see fundamental levels using your technical analysis in your charts. Dark Pool Buy Side institutions buy a stock incrementally ahead of its earnings season often weeks ahead. The fundamentals are right in your charts and are easy to see and recognize once you understand the dynamics of the Dark Pool Buy Zones and how and why these form in most charts. Being able to recognize fundamental levels is helpful for Platform Position Traders who hold a stock for several weeks. It is highly beneficial to swing traders who can prepare for the momentum speculation that comes after these patterns. It is also extremely valuable to selling short traders as you can avoid high risk sell short trades and be ready for momentum runs to the upside.
NYSE:CRM
by MarthaStokesCMT-TechniTrader
2
VERX – Vertex, Inc. – 30-Min Long Trade Setup!📈 🚀 🔹 Asset: VERX (NASDAQ) 🔹 Timeframe: 30-Min Chart 🔹 Setup Type: Trendline Bounce + Falling Wedge Breakout 📊 Trade Plan (Long Position) ✅ Entry Zone: Above $35.00 (Trendline and wedge breakout) ✅ Stop-Loss (SL): Below $34.73 (Trendline support & previous low) 🎯 Take Profit Targets 📌 TP1: $36.46 (Horizontal resistance zone) 📌 TP2: $37.43 (Major resistance / extension level) 📊 Risk-Reward Ratio Calculation 📉 Risk (SL Distance): $35.00 - $34.73 = $0.27 risk per share 📈 Reward to TP1: $36.46 - $35.00 = $1.46 (5.41:1 R/R) 📈 Reward to TP2: $37.43 - $35.00 = $2.43 (9:1 R/R) 🔍 Technical Analysis & Strategy 📌 Trendline Respect: Clean bounce from rising trendline support 📌 Falling Wedge Breakout: Break of descending resistance suggests bullish momentum shift 📌 Volume Confirmation: Small green breakout candle + bounce suggests buyers stepping in 📌 Retest & Reversal: Rejected below $35 and reclaimed, confirming support strength ⚙️ Trade Execution & Risk Management 📊 Confirm entry after a 30-min bullish close above $35.00 📉 Trailing Stop Strategy: Move SL to breakeven once TP1 is hit 💰 Partial Profit Booking Strategy ✔ Book 50% at TP1 = $36.46 ✔ Let the remaining ride toward TP2 = $37.43 ✔ Adjust stop-loss above entry to secure profits ⚠️ Breakout Failure Risk ❌ Setup invalid if price breaks below $34.73 ❌ Avoid entry without candle close above $35.00 🚀 Final Thoughts ✔ Bounce from trendline with breakout = high-conviction signal ✔ Impressive R/R potential: up to 9:1 to TP2 ✔ Clean, low-risk setup with well-defined technicals 🔗 #VERX #NASDAQ #BreakoutTrade #SwingTrading #ProfittoPath #StockSetup #TrendlineBounce 📈💹
NASDAQ:VERXLong
by ProfittoPath
eBay: (Corrective) Upside AheadAfter a month marked by elevated volatility, EBAY has recently stabilized. We anticipate a continued rise above the $71.51 resistance, where the beige wave b should ultimately form its high. Afterward, the matching beige wave c should take over, triggering declines toward the support at $49.63. However, if the stock fails once again at the $71.51 resistance and then drops directly below the upper support at $61.55, the magenta wave alt.(4) will carve out a new low near the $49.63 level. Thus, this 40% likely alternative scenario would delay the completion of beige wave b.
NASDAQ:EBAY
by MarketIntel
Why we think SBC Medical Group is set for a rebound soon.Executive Summary: SBC Medical Group Holdings Incorporated has emerged as one of the more compelling names in the post-SPAC public company landscape. Having successfully completed its business combination with Pono Capital Two, Inc. on 17 September 2024, the Japan-based aesthetic medical services provider now trades on Nasdaq under the ticker “SBC”. The SPAC merger valued the company at approximately USD1 billion and provided it with over USD11.7 million in net proceeds; capital that SBC intends to deploy strategically for international growth and asset diversification. Key Investment Pointers: At the heart of SBC Medical’s proposition is its extensive network of franchised and managed clinics in Japan, with forays into Vietnam and the United States. The company offers management services to cosmetic surgery and aesthetic dermatology clinics under the renowned “Shonan Beauty Clinic” brand, covering procurement, HR, customer loyalty, and more. The SPAC listing has provided it with both visibility and liquidity at a time when demand for aesthetic healthcare continues to rise across Asia and globally. The Group’s third-quarter results, covering the period ended 30 September 2024, underscore its operational strength. SBC posted total net revenues of USD53.1 million for Q3, a 12.3% year-on-year increase. Gross profit surged to USD43.2 million, yielding a gross margin of over 81%, reflective of the company’s high-margin service model. While operating income dipped compared to the prior year due to a one-off non-cash stock-based compensation expense of USD12.8 million, net income for the nine-month period still rose to USD40.1 million, a 60% increase compared to the same period in 2023. Its balance sheet tells a story of disciplined financial management and scalability. As of 30 September 2024, SBC held USD137.4 million in cash and cash equivalents, up from USD103 million at the end of 2023. The company also saw a significant reduction in total liabilities from USD115 million to USD91 million, while shareholder equity rose to over USD205 million. These figures point to a solid capital base capable of absorbing strategic investments and macroeconomic volatility. In a move that has drawn considerable market attention, SBC Medical has also initiated a diversification of its corporate treasury into Bitcoin. With the cryptocurrency having rebounded strongly to the USD86,000 level, SBC’s entry appears both timely and calculated. While the exact volume of the acquisition has yet to be disclosed publicly, the Group has indicated that its Bitcoin holdings are part of a broader strategy to preserve purchasing power in a globally inflationary environment and align itself with digital-native investors. The decision places SBC in the company of firms like MicroStrategy and Tesla, which have similarly sought value preservation through Bitcoin. The strategic trifecta of a successful SPAC listing, strong underlying financials, and an asset diversification play into Bitcoin positions SBC Medical favourably in the eyes of institutional investors. With Q4 results expected soon and a bullish cryptocurrency market supporting sentiment, SBC could well be on the cusp of a re-rating by the market. If its fundamentals remain sound—as recent filings suggest—they may indeed ride the same momentum wave currently lifting digital assets and new-age healthcare stocks alike.
NASDAQ:SBCLong
by HASHInvests200
$GME - More of the same weird stuffHi all, More of the same weird stuff where GME has been showing signs of wanting to spike for quite some time now. Generally last week and especially on friday it showed parabolic upwards spiking which usually happens when a move is imminent. If i was my old degenerate self, i'd be buying out of the money calls expiring this week, and i might just do that. I don't have a perfectly locked on AI model for GME yet so i don't know for sure yet what's going to happen. My model is okay but not perfect, last i have is a signal from the 11'th saying to buy 22.5 Puts and although that trade did win temporarily by dropping GME to 21.90, GME is now at 23.00 so yeah... needs a bit more time to train. Will update if i see signs of rejection/even more likely to pump. No idea when it will pump but due to the parabolic way the data is moving, it usually means the move is extremely imminent e.g day/days less than a week etc. Lets see. Will update once i have more.
NYSE:GMELong
by leenixusu
4
Reddit Has Pulled BackReddit hit a record high early last month. Will some traders see an opportunity in the current pullback? The first pattern on today’s chart is the bullish gap on October 30 after earnings beat estimates. RDDT approached the low of that session on March 10 and again last week. It bounced both times. That apparent double bottom may suggest new support has been established. Next, the rebounds occurred around the 200-day simple moving average. Holding that line may suggest an uptrend is in place. Finally, stochastics have turned up from an oversold condition. The stock also closed above its 8-day exponential moving average. Those patterns are potentially consistent with prices bottoming. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options and futures. If you're born to trade, we could be for you. See our Overview for more. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options or futures); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors. Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission and a futures commission merchant licensed with the Commodity Futures Trading Commission). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association, and a number of exchanges. TradeStation Securities, Inc. and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., both operating, and providing products and services, under the TradeStation brand and trademark. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
NYSE:RDDT
by TradeStation
GOOGLE Bottom confirmed. Laying eyes on $220.Alphabet Inc. (GOOG) has been trading within a Channel Up since the July 10 2024 High. Last week, the Bearish Leg touched the pattern's bottom, completing a -23.92% decline from the top, which is almost symmetrical to the previous Bearish Leg (-23.32%). At the same time the 1D RSI got oversold (<30.00) and recovered on a Bullish Divergence, while the 1D MA50 (blue trend-line) crossed below the 1D MA100 (green trend-line), forming a Bearish Cross. Last time we had this formation was September 06 2024 and 1 day later, the bottom (Higher Low of the Channel Up) was formed. Among all this, the 1W MA100 (red trend-line) is holding, which is the market's long-term Support since July 12 2023. As a result, we expect the new Bullish Leg to start and as the previous one did, target the 1.236 Fibonacci extension at $220.00. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:GOOGLong
by TradingShot
Tesla Financials: Q1 2025The market is currently staging a short-term rally - essentially a speculative mean reversion bounce as a reaction to -55% crash from all-time high. This move appears driven largely by retail traders seizing what it perceives as a rare opportunity to accumulate an oversold "large-caps". While retail participation and opportunistic capital are supporting the current bounce, this alone is insufficient to sustain a full recovery. As the price approaches higher levels, particularly near key supply zones, it will likely encounter significant resistance, resulting in reversal. Let's not forget the fact that figures in Tesla’s Q4 '24 financial report initiated bearish sentiment among institutional investors which resulted in market crash. Similarly, the upcoming Q1 earnings report presents a clear downside risk, as the significant events throughout this quarter will inevitably be reflected in the financial figures! Anticipated impact of significant developments on Tesla’s Q1 2025 Financial Statements 🛑 Revenue Decline • U.S. Market Weakness: Lower-than-anticipated vehicle sales in the U.S. directly reduce automotive revenue. • Severe European Slump: A significant 76% sales decline in Germany and weakness elsewhere in Europe will notably reduce international revenues. • Chinese Market Challenges: A substantial 49% sales drop in China will negatively affect one of Tesla’s crucial growth markets. • Cybertruck Weakness and Recalls: Reduced demand and multiple recalls of Cybertruck models further erode revenue growth. • Resale Value Decline and Trade-Ins: Increased vehicle trade-ins indicate lower demand, causing inventory buildup, discounting pressures, and further sales reductions. 🛑 Gross Margin Erosion • Price Reductions and Sales Incentives: Competitive pressures and lower demand likely forced Tesla to reduce vehicle prices and offer incentives, compressing gross margins. • Increased Competition from BYD: BYD’s advanced battery technology (providing 400 km of range in just 5 minutes of charging) pressures Tesla to increase R&D spending or cut prices further, negatively affecting margins. • Production Challenges (Supply Chain and Battery Issues): Ongoing global supply chain disruptions and difficulties scaling battery production significantly increase manufacturing costs, further squeezing gross margins. 🛑 Increased Operating Expenses • Recall Costs and Legal Expenses: Vehicle recalls, along with lawsuits related to product issues such as phantom braking, will significantly increase warranty provisions, legal fees, and related operating expenses. • Protests and Vandalism Costs: Public backlash and vandalism necessitate additional expenditures on security, facility repairs, and public relations initiatives. • Employee Turnover Costs: Departures of key personnel result in increased recruiting, training, onboarding, and severance expenses. 🛑 Net Income and EPS Impact • Analyst Earnings Downgrades: Already-reduced EPS projections by major analysts suggest Tesla will likely report earnings below expectations, reflecting revenue shortfalls and elevated expenses. • $1.4 Billion Financial Discrepancy: If confirmed or unresolved, this discrepancy could lead to substantial asset impairments, restatements, or write-downs, negatively impacting net income and earnings per share (EPS). 🛑 Cash Flow and Liquidity Pressures • Lower Operating Cash Flows: Reduced revenue coupled with rising operating costs (including recalls, lawsuits, security, and PR spending) severely diminish cash generated from business operations. • Increased Capital Expenditures: Additional CapEx is likely required to address battery production bottlenecks and delays in autonomous driving technology development, resulting in elevated investing cash outflows. • Investor Divestment and Stock Volatility: Negative investor sentiment could lead to costly equity financing conditions if Tesla needs to raise capital, adversely affecting financing cash flows and liquidity. 🛑 Balance Sheet Risks • Rising Inventory Levels: Weak sales combined with continued vehicle production may lead to increased inventory levels, reducing cash and potentially requiring markdowns or provisions. • Debt and Liquidity Challenges: Deteriorating credit metrics or covenant breaches could make refinancing existing debt more expensive or complicated, negatively impacting Tesla’s financial stability.
NASDAQ:TSLA
by fract
6
$SNOW $200 target, sooner than laterHello. Not much analysis here besides a monster gut feeling. NYSE:SNOW has earnings May 21. I’m looking to get in $200c for May 16 expiration. For some reason this name can’t scorch $200 and I believe it should. If NASDAQ:CRWD moves the way it does so can $SNOW. I think it’s made a strong support and mental level at $150. I was apart of the latest push to $180-$190 before its most recent earnings which jolted it from $150s to $180 AND it got sent back to that $150 to $160 level. I think this is a high conviction swing especially into earnings; premiums can go up off the IV. NFA. WSL.
NYSE:SNOWLong
by wallstreetloser001